Latest Cell encapsulation Stories
NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine
-- Potentially transformative therapy for individuals with type 1 diabetes nearing major milestone -- NEW YORK and SAN DIEGO, Feb.
Austrianova, announced today that Nuvilex, Inc, has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology, Cell-in-a-Box®, for the development
A cheaper, more efficient technique for developing complex protein drugs from bacteria has been developed at the University of Sheffield.
- A poem in which the author retracts something said in an earlier poem.